Search by Drug Name or NDC

    NDC 72855-0102-01 Rivastigmine Transdermal System 13.3 mg/24h Details

    Rivastigmine Transdermal System 13.3 mg/24h

    Rivastigmine Transdermal System is a TRANSDERMAL PATCH, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Adhexpharma. The primary component is RIVASTIGMINE.

    Product Information

    NDC 72855-0102
    Product ID 72855-102_087b5a9e-3157-abc7-e063-6394a90a554b
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Rivastigmine Transdermal System
    Proprietary Name Suffix n/a
    Non-Proprietary Name Rivastigmine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form PATCH, EXTENDED RELEASE
    Route TRANSDERMAL
    Active Ingredient Strength 13.3
    Active Ingredient Units mg/24h
    Substance Name RIVASTIGMINE
    Labeler Name Adhexpharma
    Pharmaceutical Class Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209063
    Listing Certified Through 2024-12-31

    Package

    NDC 72855-0102-01 (72855010201)

    NDC Package Code 72855-102-01
    Billing NDC 72855010201
    Package 30 POUCH in 1 CARTON (72855-102-01) / 1 PATCH in 1 POUCH (72855-102-02) / 24 h in 1 PATCH
    Marketing Start Date 2019-12-19
    NDC Exclude Flag N
    Pricing Information N/A